SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

With no major difference for the quarter endedSeptember 2024 , the total revenue stood at Rs. 51277.10  millions.A slender decline of -2.85% was recorded to Rs. 8632.90  millions from Rs. 8886.30 millions in the corresponding previous quarter.The company reported a degrowth in operating Profit to 14249.20 millions from 14928.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 51277.10 50962.10 0.62 96257.80 95622.80 0.66 202751.70 208121.40 -2.58
Other Income 2146.30 1159.30 85.14 2973.70 2794.70 6.40 5534.80 3292.90 68.08
PBIDT 14249.20 14928.60 -4.55 22687.30 26051.60 -12.91 60533.70 67518.90 -10.35
Interest 2437.50 1936.30 25.88 4598.30 3515.70 30.79 7840.80 4721.80 66.06
PBDT 11811.70 12992.30 -9.09 18089.00 21043.80 -14.04 50502.70 33419.20 51.12
Depreciation 2855.30 3927.10 -27.29 6553.40 8079.80 -18.89 16006.20 16008.70 -0.02
PBT 8956.40 9065.20 -1.20 11535.60 12964.00 -11.02 34496.50 17410.50 98.14
TAX 323.50 178.90 80.83 524.50 271.30 93.33 5914.70 503.30 1075.18
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 8632.90 8886.30 -2.85 11011.10 12692.70 -13.25 28581.80 16907.20 69.05
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 27.79 29.29 -5.14 23.57 27.24 -13.49 29.86 32.44 -7.97

Sun Pharma Inds. Share Price

1867.80 4.35 (0.23%)
23-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1867.80
Dr. Reddys Labs. 1301.30
Cipla 1433.10
Zydus Lifesciences 1112.10
Lupin 2356.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: